BiotechTube
Discover
News
Company
Sign in
BiotechTube
Home
/
Alpha-9 Oncology
/
Paul Blanchfield
PB
Paul Blanchfield
Chief Executive Officer
Alpha-9 Oncology
Therapeutic Areas
Oncology
Alpha-9 Oncology Pipeline
Drug
Indication
Phase
A9-3202
Not Specified (Imaging Agent)
Phase 1
A9-3408
Not Specified
Phase 1
Leadership Team at Alpha-9 Oncology
FB
François Bénard, MD
Co-Founder
KL
Kuo-Shyan Lin, PhD
Co-Founder
DP
David Perrin, PhD
Co-Founder
View full Alpha-9 Oncology profile